Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-angiogenic Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06482801
What this trial is testing

Checkpoint Inhibitor Combinations Therapy as First Line for HCC Via IT

Who this might be right for
Liver CancerAntibody
Second Affiliated Hospital of Guangzhou Medical University 90
Not applicableUnknownNCT04952688
What this trial is testing

Modifications in Retinal Microvascularization With Targeted Anti-angiogenic Therapy in Colorectal Cancer

Who this might be right for
Colorectal Cancer
Centre Georges Francois Leclerc 30
Testing effectiveness (Phase 2)UnknownNCT03267654
What this trial is testing

Gefitinib With Chemotherapy or Anti-angiogenesis in NSCLC Patients With Bim Deletion or Low EGFR Mutation Abundance

Who this might be right for
Non-small-cell Lung Cancer
Qilu Pharmaceutical Co., Ltd. 100
Testing effectiveness (Phase 2)Looking for participantsNCT06646198
What this trial is testing

TIPS Plus Half-dose Donafenib in AHCC with PVTT-associated Portal Hypertension

Who this might be right for
Hepatocellular Carcinoma with PVTT
Fei Gao 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07148427
What this trial is testing

Immunotherapy Combined With Anti-angiogenic Therapy and Chemotherapy for Gastric/Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastric/Gastroesophageal Junction Adenocarcinoma
The First Affiliated Hospital with Nanjing Medical University 40
Large-scale testing (Phase 3)Study completedNCT01223027
What this trial is testing

Study of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
Novartis Pharmaceuticals 564
Testing effectiveness (Phase 2)UnknownNCT04191889
What this trial is testing

A Trial of Hepatic Arterial Infusion Combined With Apatinib and Camrelizumab for C-staged Hepatocellular Carcinoma in BCLC Classification

Who this might be right for
C-staged Hepatocellular Carcinoma in BCLC Classification
Sun Yat-sen University 47
Testing effectiveness (Phase 2)Study completedNCT01752049
What this trial is testing

Topical Anti-angiogenic Therapy for Telangiectasia in HHT: Proof of Concept

Who this might be right for
Hereditary Hemorrhagic Telangiectasia
Unity Health Toronto 5
Testing effectiveness (Phase 2)Study completedNCT01753713
What this trial is testing

Dovitinib in Treating Patients With Recurrent or Progressive Glioblastoma

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+1 more
Manmeet Ahluwalia, MD 33
Not applicableStudy completedNCT01811108
What this trial is testing

Assessment of Clinical Practice Administration of Chemotherapy and Anti-angiogenic Agent (Bevacizumab) in Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Hellenic Oncology Research Group 670
Testing effectiveness (Phase 2)Study completedNCT00023738
What this trial is testing

Chemotherapy, SU5416, Radiation Therapy, and Surgery in Treating Patients With Soft Tissue Sarcoma

Who this might be right for
Sarcoma
Radiation Therapy Oncology Group
Not applicableStudy completedNCT04566185
What this trial is testing

Evaluation of the Predictive Value of 18F-fluorodeoxyglucose Positron Emission Tomography and Brain Perfusion Computed Tomography for the Efficacy of Anti-angiogenic Therapy (Bevacizumab) in Recurrent Glioblastoma

Who this might be right for
Glioblastoma
Centre Hospitalier Universitaire de Nīmes 14
Testing effectiveness (Phase 2)UnknownNCT04725448
What this trial is testing

Toripalimab Combined With Bevacizumab, Nab-paclitaxel and Carboplatin for Untreated Metastatic Pulmonary Sarcomatoid Carcinoma

Who this might be right for
Pulmonary Sarcomatoid CarcinomaNon-small Cell Lung CancerLung Diseases+1 more
Sichuan Cancer Hospital and Research Institute 27
Early research (Phase 1)Looking for participantsNCT06307249
What this trial is testing

Precision Therapy for Solid Tumors: Synergistic CDK4/6 Inhibition and Anti-VEGF Targeting LncRNA

Who this might be right for
CancerSolid TumorColorectal Cancer+7 more
Lebanese University 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07151209
What this trial is testing

Immunotherapy Combined With Anti-angiogenic Therapy and Chemotherapy for Potentially Resectable MSI-H, dMMR Locally Advanced Gastric or Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastric or Gastroesophageal Junction Adenocarcinoma
The First Affiliated Hospital with Nanjing Medical University 20
Not applicableStudy completedNCT07375901
What this trial is testing

The Blood-Aqeous Barrier During Anti-Angiogenic Therapy in Exudative Age-Related Macular Degeneration

Who this might be right for
AMD
The Filatov Institute of Eye Diseases and Tissue Therapy 30
Testing effectiveness (Phase 2)Ended earlyNCT02104011
What this trial is testing

Treatment of Renal Angiomyolipomas in Tuberous Sclerosis by Beta-blockers

Who this might be right for
Renal AngiomyolipomasTuberous Sclerosis
University Hospital, Bordeaux 2
Early research (Phase 1)Study completedNCT00807859
What this trial is testing

Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer

Who this might be right for
Breast CancerBreast NeoplasmsBreast Tumors+7 more
Amgen 65
Not applicableNot Yet RecruitingNCT06470178
What this trial is testing

A Real-World Study of Neoadjuvant/Conversion Therapy for Colorectal Cancer With Chemotherapy And Anti-Angiogenic Targeted Agents

Who this might be right for
Colorectal Cancer
Wuhan University 70
Testing effectiveness (Phase 2)WithdrawnNCT01633255
What this trial is testing

[18]F-Fluciclatide for Kidney Cancer Imaging Studies and Treatment

Who this might be right for
Kidney Neoplasms
National Cancer Institute (NCI)
Next Page